BIO’s investment in Maple Etanol SRL

 News

BIO’s investment in Maple Etanol SRL

20-10-2021

On the 27th of September 2021, Oxfam Belgium published the report ″Fuelling human rights violations″ addressing the problematic consequences of a bioethanol project co-financed by BIO. Oxfam's testimonies on the excesses concerning environment and health are mostly dated after 2015, two years after Maple Etanol prematurely reimbursed BIO and left our portfolio. Since then BIO no longer had access to the monitoring reports either.

Read more
Lendable to Launch $100 million Emerging Market Fintech Fund with Leading Impact and DFI Investors

 News

Lendable to Launch $100 million Emerging Market Fintech Fund with Leading Impact and DFI Investors

12-10-2021

Lendable Inc., a leading emerging market fintech credit provider, is targeting a ground-breaking USD 100 million closed-ended fund focused on emerging and frontier market fintech investments.

Read more
BIO invests in vaccine production in Africa

 News

BIO invests in vaccine production in Africa

05-10-2021

Through European Financing Partners - a joint venture between the European Investment Bank (EIB) and several European DFIs - the Belgian Investment Company for Developing Countries (BIO) is investing EUR 1.56 million in the production of covid and other vaccines in Africa.

Read more
Greener money

 News

Greener money

31-08-2021

Money is getting greener. The superlative in sustainable investing today is "impact investing". A growing global market that is already worth more than $700 billion.

Article originally appeared in MT Magazine in Dutch.

Read more
Belgian impact fund focused on the Indian rural economy hits first close of USD 60 M

 News

Belgian impact fund focused on the Indian rural economy hits first close of USD 60 M

26-07-2021

A group of international investors announce the successful first closing of the Incofin India Progress Fund (IPF) with USD 60 million of commitments. The fund will make private equity investments in the Indian agri food value chain and in financial inclusion for rural entrepreneurs in India. The committed capital comes from a diverse set of private and institutional investors including Korys, CDC, Proparco, the Belgian Investment Company for Developing Countries (BIO), the SDG Frontier Fund, the King Baudouin Foundation and several Belgian family offices.

Read more
SDB bank will issue 10% shares to Belgian Investment Company for Developing Countries (BIO)

 News

SDB bank will issue 10% shares to Belgian Investment Company for Developing Countries (BIO)

09-07-2021

The Belgian Investment Company for Developing Countries (BIO) agreed with SDB bank, a pioneering provider of financial services, to take up a 10% share of the bank, amounting to Rs. 925 million at Rs. 51.50 a share, via SDB bank’s Secondary Public Offering (SPO).

Read more
Investisseurs & Partenaires and BIO invest in Ghanaian company XpressGas

 News

Investisseurs & Partenaires and BIO invest in Ghanaian company XpressGas

24-06-2021

The impact investing group Investisseurs & Partenaires (I&P) and the Belgian Investment Company for Developing countries (BIO) are pleased to announce a USD 6 million investment in XpressGas, a pioneering distributor of Liquefied Petroleum Gas (LPG) in Ghana. LPG offers an efficient and environmentally friendly alternative to traditional dirty fuels currently being used, particularly for peri-urban and rural areas.

Read more
EDFIs strengthen joint financing platform to promote private sector development

 News

EDFIs strengthen joint financing platform to promote private sector development

27-05-2021

EDFI Management Company (EDFI MC) is reinforced to boost collaboration among European Development Finance Institutions as part of the Team Europe approach.

Read more
Ascent announces first close of Ascent Rift Valley Fund II

 News

Ascent announces first close of Ascent Rift Valley Fund II

18-05-2021

African private equity fund manager Ascent today announced the first rolling close of its Ascent Rift Valley Fund II (ARVF II) at more than USD 100 million, significantly exceeding its initial target of USD 80 million. The final close of ARVF II, with a target of USD 120 million, is expected in December 2021.

Read more